Join
Live feed
·
INSIDERFilingvia Quantisnow
Rigel Pharmaceuticals Inc. logo

Director Ali-Jackson Kamil sold $87,500 worth of shares (2,500 units at $35.00) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 10,125 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RIGL (Rigel Pharmaceuticals Inc.) and more on Quantisnow.